Growth Metrics

Rigel Pharmaceuticals (RIGL) Profit After Tax (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -96.77%
Dec 31, 2025 860.81%
Sep 30, 2025 -53.20%
Jun 30, 2025 420.82%
Mar 31, 2025 -20.19%
Dec 31, 2024 15.46%
Sep 30, 2024 1,305.92%
Jun 30, 2024 87.51%
Mar 31, 2024 -1,219.00%
Dec 31, 2023 112.95%
Sep 30, 2023 13.76%
Jun 30, 2023 51.24%
Mar 31, 2023 -1,066.17%
Dec 31, 2022 107.36%
Sep 30, 2022 -41.10%
Jun 30, 2022 50.84%
Mar 31, 2022 -21.22%
Dec 31, 2021 -8.06%
Sep 30, 2021 -51.60%
Jun 30, 2021 -134.99%
Mar 31, 2021 305.33%
Dec 31, 2020 -35.72%
Sep 30, 2020 19.36%
Jun 30, 2020 -182.74%
Mar 31, 2020 223.51%
Dec 31, 2019 -49.70%
Sep 30, 2019 44.24%
Jun 30, 2019 -17.09%
Mar 31, 2019 -645.17%
Dec 31, 2018 113.58%
Sep 30, 2018 7.01%
Jun 30, 2018 -4.81%
Mar 31, 2018 5.74%
Dec 31, 2017 -46.49%
Sep 30, 2017 7.77%
Jun 30, 2017 -19.33%
Mar 31, 2017 -2.35%
Dec 31, 2016 30.72%
Sep 30, 2016 -67.21%
Jun 30, 2016 22.51%
Mar 31, 2016 -37.65%
Dec 31, 2015 -88.60%
Sep 30, 2015 51.65%
Jun 30, 2015 23.53%
Mar 31, 2015 18.50%
Dec 31, 2014 -6.38%
Sep 30, 2014 17.35%
Jun 30, 2014 -13.85%
Mar 31, 2014 -32.15%
Dec 31, 2013 29.16%
Sep 30, 2013 -4.64%
Jun 30, 2013 10.97%
Mar 31, 2013 -0.33%
Dec 31, 2012 -0.13%
Sep 30, 2012 -2.90%
Jun 30, 2012 -6.75%
Mar 31, 2012 10.13%
Dec 31, 2011 -43.81%
Sep 30, 2011 16.50%
Jun 30, 2011 -3.33%
Mar 31, 2011 -6.03%
Dec 31, 2010 -138.86%
Sep 30, 2010 86.59%